|

18-FDG Clinical Trials

2 actively recruiting trials

▲ +1 trial since August 2026

Pipeline

Early 1: 1

Top Sponsors

  • Peking University Cancer Hospital & Institute1
  • Peking Union Medical College Hospital1

Indications

  • Cancer2
  • Iodine-resistant Thyroid Cancer1
  • NETs1
  • Meningioma1
  • Solid Tumor1

Other2 trials

A Dual-targeting Tracer TATE-RGD for the Diagnosis of SSTR- and RGD- Positive Tumors
Early 1
MMP14(MT1-MMP) Targeting Bicyclic Peptide Probe for PET Imaging in Solid Tumors

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.